BRISTOL-MYERS SQUIBB COMPANY Proceeds from (Repayments of) Short-term Debt
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Proceeds from (Repayments of) Short-term Debt of $3.07 billion for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2024-04-25
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2024-03-31 was $3.07B, a 2298.44% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2023-12-31 was -$353.00M, a 359.56% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2023-09-30 was -$10.00M.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2023-06-30 was $115.00M, a 30.68% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for fiscal 2023 was -$120.00M, a 161.86% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for fiscal 2022 was $194.00M.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for fiscal 2021 was -$160.00M.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from (repayments of) short-term debt for fiscal 2020 was -$267.00M, a 303.82% decline from fiscal 2019.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 9 month as first filed | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $3.07B 10-Q · filed 2024-04-25 | $2.72B derived: sum of 2 quarters · filed 2024-04-25 | $2.71B derived: sum of 3 quarters · filed 2024-04-25 | $2.82B derived: sum of 4 quarters · filed 2024-04-25 | |
| 2023-12-31 | -$353.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$363.00M derived: sum of 2 quarters · filed 2024-02-13 | -$248.00M derived: sum of 3 quarters · filed 2024-02-13 | -$120.00M 10-K · filed 2024-02-13 | |
| 2023-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $105.00M derived: sum of 2 quarters · filed 2023-10-26 | $233.00M 10-Q · filed 2023-10-26 | $369.00M derived: sum of 4 quarters · filed 2024-04-25 | |
| 2023-06-30 | $115.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $243.00M 10-Q · filed 2023-07-27 | $379.00M derived: sum of 3 quarters · filed 2024-04-25 | $307.00M derived: sum of 4 quarters · filed 2024-04-25 | |
| 2023-03-31 | $128.00M 10-Q · filed 2024-04-25 | $264.00M derived: sum of 2 quarters · filed 2024-04-25 | $192.00M derived: sum of 3 quarters · filed 2024-04-25 | $280.00M derived: sum of 4 quarters · filed 2024-04-25 | |
| 2022-12-31 | $136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $64.00M derived: sum of 2 quarters · filed 2024-02-13 | $152.00M derived: sum of 3 quarters · filed 2024-02-13 | $194.00M 10-K · filed 2024-02-13 | |
| 2022-09-30 | -$72.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $16.00M derived: sum of 2 quarters · filed 2023-10-26 | $58.00M 10-Q · filed 2023-10-26 | -$56.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-06-30 | $88.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $130.00M 10-Q · filed 2023-07-27 | $16.00M derived: sum of 3 quarters · filed 2024-02-13 | $155.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-03-31 | $42.00M 10-Q · filed 2023-04-27 | -$72.00M derived: sum of 2 quarters · filed 2024-02-13 | $67.00M derived: sum of 3 quarters · filed 2024-02-13 | -$56.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2021-12-31 | -$114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $25.00M derived: sum of 2 quarters · filed 2024-02-13 | -$98.00M derived: sum of 3 quarters · filed 2024-02-13 | -$160.00M 10-K · filed 2024-02-13 | |
| 2021-09-30 | $139.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $16.00M derived: sum of 2 quarters · filed 2022-10-26 | -$46.00M 10-Q · filed 2022-10-26 | -$49.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-06-30 | -$123.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$185.00M 10-Q · filed 2022-07-27 | -$188.00M derived: sum of 3 quarters · filed 2023-02-14 | -$430.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | -$62.00M 10-Q · filed 2022-04-29 | -$65.00M derived: sum of 2 quarters · filed 2023-02-14 | -$307.00M derived: sum of 3 quarters · filed 2023-02-14 | -$355.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$245.00M derived: sum of 2 quarters · filed 2023-02-14 | -$293.00M derived: sum of 3 quarters · filed 2023-02-14 | -$267.00M 10-K · filed 2023-02-14 | |
| 2020-09-30 | -$242.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$290.00M derived: sum of 2 quarters · filed 2021-10-27 | -$264.00M 10-Q · filed 2021-10-27 | -$248.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-06-30 | -$48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$22.00M 10-Q · filed 2021-07-28 | -$6.00M derived: sum of 3 quarters · filed 2022-02-09 | $25.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-03-31 | $26.00M 10-Q · filed 2021-04-29 | $42.00M derived: sum of 2 quarters · filed 2022-02-09 | $73.00M derived: sum of 3 quarters · filed 2022-02-09 | $230.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2019-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $47.00M derived: sum of 2 quarters · filed 2022-02-09 | $204.00M derived: sum of 3 quarters · filed 2022-02-09 | $131.00M 10-K · filed 2022-02-09 | |
| 2019-09-30 | $31.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $188.00M derived: sum of 2 quarters · filed 2020-11-05 | $115.00M 10-Q · filed 2020-11-05 | $189.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | $157.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $84.00M 10-Q · filed 2020-08-06 | $158.00M derived: sum of 3 quarters · filed 2021-02-10 | $87.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | -$73.00M 10-Q · filed 2020-05-07 | $1.00M derived: sum of 2 quarters · filed 2021-02-10 | -$70.00M derived: sum of 3 quarters · filed 2021-02-10 | -$272.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2018-12-31 | $74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $3.00M derived: sum of 2 quarters · filed 2021-02-10 | -$199.00M derived: sum of 3 quarters · filed 2021-02-10 | -$543.00M 10-K · filed 2021-02-10 | |
| 2018-09-30 | -$71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$273.00M derived: sum of 2 quarters · filed 2019-10-31 | -$617.00M 10-Q · filed 2019-10-31 | -$1.09B derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | -$202.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$546.00M 10-Q · filed 2019-07-25 | -$1.02B derived: sum of 3 quarters · filed 2020-02-24 | -$119.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | -$344.00M 10-Q · filed 2019-04-25 | -$815.00M derived: sum of 2 quarters · filed 2020-02-24 | $83.00M derived: sum of 3 quarters · filed 2020-02-24 | $191.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | -$471.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $427.00M derived: sum of 2 quarters · filed 2020-02-24 | $535.00M derived: sum of 3 quarters · filed 2020-02-24 | $727.00M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $898.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $1.01B derived: sum of 2 quarters · filed 2018-10-25 | $1.20B 10-Q · filed 2018-10-25 | $1.22B derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $108.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $300.00M 10-Q · filed 2018-07-26 | $323.00M derived: sum of 3 quarters · filed 2019-02-25 | $408.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $192.00M 10-Q · filed 2018-04-26 | $215.00M derived: sum of 2 quarters · filed 2019-02-25 | $300.00M derived: sum of 3 quarters · filed 2019-02-25 | $350.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $108.00M derived: sum of 2 quarters · filed 2019-02-25 | $158.00M derived: sum of 3 quarters · filed 2019-02-25 | $125.00M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $135.00M derived: sum of 2 quarters · filed 2017-10-26 | $102.00M 10-Q · filed 2017-10-26 | -$401.00M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $17.00M 10-Q · filed 2017-07-27 | -$486.00M derived: sum of 3 quarters · filed 2018-02-13 | -$599.00M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-03-31 | -$33.00M 10-Q · filed 2017-04-27 | -$536.00M derived: sum of 2 quarters · filed 2018-02-13 | -$649.00M derived: sum of 3 quarters · filed 2018-02-13 | -$222.00M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2015-12-31 | -$503.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$616.00M derived: sum of 2 quarters · filed 2018-02-13 | -$189.00M derived: sum of 3 quarters · filed 2018-02-13 | -$449.00M 10-K · filed 2018-02-13 | |
| 2015-09-30 | -$113.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $314.00M derived: sum of 2 quarters · filed 2016-10-27 | $54.00M 10-Q · filed 2016-10-27 | $253.00M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2015-06-30 | $427.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $167.00M 10-Q · filed 2016-07-28 | $366.00M derived: sum of 3 quarters · filed 2017-02-21 | $406.00M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2015-03-31 | -$260.00M 10-Q · filed 2016-04-28 | -$61.00M derived: sum of 2 quarters · filed 2017-02-21 | -$21.00M derived: sum of 3 quarters · filed 2017-02-21 | $63.00M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2014-12-31 | $199.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $239.00M derived: sum of 2 quarters · filed 2017-02-21 | $323.00M derived: sum of 3 quarters · filed 2017-02-21 | $244.00M 10-K · filed 2017-02-21 | |
| 2014-09-30 | $40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $124.00M derived: sum of 2 quarters · filed 2015-10-27 | $45.00M 10-Q · filed 2015-10-27 | -$245.00M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-06-30 | $84.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $5.00M 10-Q · filed 2015-07-23 | -$285.00M derived: sum of 3 quarters · filed 2016-02-12 | $282.00M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-03-31 | -$79.00M 10-Q · filed 2015-04-28 | -$369.00M derived: sum of 2 quarters · filed 2016-02-12 | $198.00M derived: sum of 3 quarters · filed 2016-02-12 | -$432.00M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2013-12-31 | -$290.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $277.00M derived: sum of 2 quarters · filed 2016-02-12 | -$353.00M derived: sum of 3 quarters · filed 2016-02-12 | $198.00M 10-K · filed 2016-02-12 | |
| 2013-09-30 | $567.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$63.00M derived: sum of 2 quarters · filed 2014-10-24 | $488.00M 10-Q · filed 2014-10-24 | $517.00M derived: sum of 4 quarters · filed 2015-02-13 | |
| 2013-06-30 | -$630.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$79.00M 10-Q · filed 2014-07-24 | -$50.00M derived: sum of 3 quarters · filed 2015-02-13 | -$151.00M derived: sum of 4 quarters · filed 2015-02-13 | |
| 2013-03-31 | $551.00M 10-Q · filed 2014-04-29 | $580.00M derived: sum of 2 quarters · filed 2015-02-13 | $479.00M derived: sum of 3 quarters · filed 2015-02-13 | $570.00M derived: sum of 4 quarters · filed 2015-02-13 | |
| 2012-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$72.00M derived: sum of 2 quarters · filed 2015-02-13 | $19.00M derived: sum of 3 quarters · filed 2015-02-13 | $49.00M 10-K · filed 2015-02-13 | |
| 2012-09-30 | -$101.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$10.00M derived: sum of 2 quarters · filed 2013-10-23 | $20.00M 10-Q · filed 2013-10-23 | -$48.00M derived: sum of 4 quarters · filed 2014-02-14 | |
| 2012-06-30 | $91.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $121.00M 10-Q · filed 2013-07-25 | $53.00M derived: sum of 3 quarters · filed 2014-02-14 | $50.00M derived: sum of 4 quarters · filed 2014-02-14 | |
| 2012-03-31 | $30.00M 10-Q · filed 2013-04-25 | -$38.00M derived: sum of 2 quarters · filed 2014-02-14 | -$41.00M derived: sum of 3 quarters · filed 2014-02-14 | $11.00M derived: sum of 4 quarters · filed 2014-02-14 | |
| 2011-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$71.00M derived: sum of 2 quarters · filed 2014-02-14 | -$19.00M derived: sum of 3 quarters · filed 2014-02-14 | -$1.00M 10-K · filed 2014-02-14 | |
| 2011-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $49.00M derived: sum of 2 quarters · filed 2012-10-24 | $67.00M 10-Q · filed 2012-10-24 | -$20.00M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-06-30 | $52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $70.00M 10-Q · filed 2012-07-25 | -$17.00M derived: sum of 3 quarters · filed 2013-02-15 | -$24.00M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-03-31 | $18.00M 10-Q · filed 2012-04-26 | -$69.00M derived: sum of 2 quarters · filed 2013-02-15 | -$76.00M derived: sum of 3 quarters · filed 2013-02-15 | $2.00M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2010-12-31 | -$87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$94.00M derived: sum of 2 quarters · filed 2013-02-15 | -$16.00M derived: sum of 3 quarters · filed 2013-02-15 | -$33.00M 10-K · filed 2013-02-15 | |
| 2010-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $71.00M derived: sum of 2 quarters · filed 2011-10-27 | $54.00M 10-Q · filed 2011-10-27 | $12.00M 10-Q · filed 2010-10-26 | $29.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $61.00M 10-Q · filed 2011-07-28 | $36.00M derived: sum of 3 quarters · filed 2012-02-17 | $65.00M derived: sum of 4 quarters · filed 2012-02-17 | |
| 2010-03-31 | -$17.00M 10-Q · filed 2011-04-28 | -$42.00M derived: sum of 2 quarters · filed 2012-02-17 | -$13.00M derived: sum of 3 quarters · filed 2012-02-17 | -$45.00M derived: sum of 4 quarters · filed 2012-02-17 | |
| 2009-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $4.00M derived: sum of 2 quarters · filed 2012-02-17 | -$28.00M derived: sum of 3 quarters · filed 2012-02-17 | -$26.00M 10-K · filed 2012-02-17 | |
| 2009-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$3.00M derived: sum of 2 quarters · filed 2010-10-26 | -$1.00M 10-Q · filed 2010-10-26 | $28.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | -$32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | -$30.00M 10-Q · filed 2010-07-22 | -$1.00M derived: sum of 3 quarters · filed 2011-02-18 | -$1.62B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $2.00M 10-Q · filed 2010-04-29 | $31.00M derived: sum of 2 quarters · filed 2011-02-18 | -$1.59B derived: sum of 3 quarters · filed 2011-02-18 | ||
| 2008-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$1.59B derived: sum of 2 quarters · filed 2011-02-18 | -$1.69B 10-K · filed 2011-02-18 | ||
| 2008-09-30 | -$1.62B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | -$1.72B 10-Q · filed 2009-10-22 | |||
| 2008-06-30 | -$99.00M 10-Q · filed 2009-07-23 | ||||
| 2007-12-31 | -$33.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |